Patent · US Active

Anti-IL-13 receptor alpha 2 antibodies and antibody-drug conjugates

US9828428B2 · kind B2 · utility

2Cited by
2References
23Claims
0Family size

Assignee

Inventors

Key dates

Filing dateOct 30, 2013
Grant dateNov 28, 2017
Priority date—
Expiry dateOct 30, 2033

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/7155
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

Disclosed herein are anti-IL-13-Rα2 antibodies and antibody drug conjugates and methods for preparing and using the same.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.